US 10407405
Nuclear transport modulators and uses thereof
granted A61PA61P11/00A61P17/02
Quick answer
US patent 10407405 (Nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P11/00, A61P17/02, A61P25/00, A61P25/28